604
Views
45
CrossRef citations to date
0
Altmetric
Research Paper

LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors

Pages 176-184 | Received 06 Mar 2009, Accepted 06 Apr 2009, Published online: 30 Apr 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Cécile Desjobert, Mounir El Maï, Tom Gérard-Hirne, Dominique Guianvarc'h, Arnaud Carrier, Cyrielle Pottier, Paola B Arimondo & Joëlle Riond. (2015) Combined analysis of DNA methylation and cell cycle in cancer cells. Epigenetics 10:1, pages 82-91.
Read now
Sonia Fabris, Valentina Bollati, Luca Agnelli, Fortunato Morabito, Valeria Motta, Giovanna Cutrona, Serena Matis, Anna Grazia Recchia, Vincenzo Gigliotti, Massimo Gentile, Giorgio Lambertenghi Deliliers, Pier Alberto Bertazzi, Manlio Ferrarini, Antonino Neri & Andrea Baccarelli. (2011) Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. Epigenetics 6:2, pages 188-194.
Read now

Articles from other publishers (43)

Krisztina A Szigeti, Barbara K Barták, Zsófia B Nagy, Sára Zsigrai, Márton Papp, Eszter Márkus, Peter Igaz, István Takács, Béla Molnár & Alexandra Kalmár. (2022) Methodological and Biological Factors Influencing Global DNA Methylation Results Measured by LINE-1 Pyrosequencing Assay in Colorectal Tissue and Liquid Biopsy Samples. International Journal of Molecular Sciences 23:19, pages 11608.
Crossref
Hadjer Namous, Camila Urbano Braz, Yiding Wang & Hasan Khatib. (2022) The Activation of Protamine 1 Using Epigenome Editing Decreases the Proliferation of Tumorigenic Cells. Frontiers in Genome Editing 4.
Crossref
Teita Ishizaki, Jumpei Yamazaki, Shinji Meagawa, Nozomu Yokoyama, Keisuke Aoshima, Mitsuyoshi Takiguchi & Takashi Kimura. (2020) Long interspersed nucleotide element‐1 hypomethylation in canine malignant mucosal melanoma. Veterinary and Comparative Oncology 18:4, pages 854-860.
Crossref
Dzjemma Sarkisjan, Joris R. Julsing, Btissame El Hassouni, Richard J. Honeywell, Ietje Kathmann, Larry H. Matherly, Young B. Lee, Deog J. Kim & Godefridus J. Peters. (2020) RX-3117 (Fluorocyclopentenyl-Cytosine)-Mediated Down-Regulation of DNA Methyltransferase 1 Leads to Protein Expression of Tumor-Suppressor Genes and Increased Functionality of the Proton-Coupled Folate Carrier. International Journal of Molecular Sciences 21:8, pages 2717.
Crossref
Simon Crabb, Sarah J. Danson, James W. F. Catto, Cathy McDowell, James N. Lowder, Joshua Caddy, Denise Dunkley, Jessica Rajaram, Deborah Ellis, Stephanie Hill, David Hathorn, Amy Whitehead, Mihalis Kalevras, Robert Huddart & Gareth Griffiths. (2018) SPIRE – combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial. Trials 19:1.
Crossref
M. Khalid, P. BojangJr.Jr., A.A.I. Hassanin, E.C. Bowers, E.M. Reyes-Reyes, I.N. Ramos & K.S. Ramos. (2018) Line-1: Implications in the etiology of cancer, clinical applications, and pharmacologic targets. Mutation Research/Reviews in Mutation Research 778, pages 51-60.
Crossref
Meixia Chen, Jing Nie, Yang Liu, Xiang Li, Yan Zhang, Malcolm V. Brock, Kaichao Feng, Zhiqiang Wu, Xiaolei Li, Lu Shi, Suxia Li, Mingzhou Guo, Qian Mei & Weidong Han. (2018) Phase Ib/II study of safety and efficacy of low‐dose decitabine‐primed chemoimmunotherapy in patients with drug‐resistant relapsed/refractory alimentary tract cancer. International Journal of Cancer 143:6, pages 1530-1540.
Crossref
Robert Molokie, Donald Lavelle, Michel Gowhari, Michael Pacini, Lani Krauz, Johara Hassan, Vinzon Ibanez, Maria A. Ruiz, Kwok Peng Ng, Philip Woost, Tomas Radivoyevitch, Daisy Pacelli, Sherry Fada, Matthew Rump, Matthew Hsieh, John F. Tisdale, James Jacobberger, Mitch Phelps, James Douglas Engel, Santhosh Saraf, Lewis L. Hsu, Victor Gordeuk, Joseph DeSimone & Yogen Saunthararajah. (2017) Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study. PLOS Medicine 14:9, pages e1002382.
Crossref
Juozas Kupcinskas, Ruta Steponaitiene, Cosima Langner, Giedre Smailyte, Jurgita Skieceviciene, Limas Kupcinskas, Peter Malfertheiner & Alexander Link. (2017) LINE-1 hypomethylation is not a common event in preneoplastic stages of gastric carcinogenesis. Scientific Reports 7:1.
Crossref
A. A. Ponomaryova, N. V. Cherdyntseva, A. A. Bondar, A. Y. Dobrodeev, A. A. Zavyalov, S. A. Tuzikov, V. V. Vlassov, E. L. Choinzonov, P. P. Laktionov & E. Y. Rykova. (2017) Dynamics of LINE-1 retrotransposon methylation levels in circulating DNA from lung cancer patients undergoing antitumor therapy. Molecular Biology 51:4, pages 549-554.
Crossref
Peter A. Jones, Jean-Pierre J. Issa & Stephen Baylin. (2016) Targeting the cancer epigenome for therapy. Nature Reviews Genetics 17:10, pages 630-641.
Crossref
Edwin J. C. G. van den Oord, Shaunna L. Clark, Lin Ying Xie, Andrey A. Shabalin, Mikhail G. Dozmorov, Gaurav Kumar, Vladimir I. Vladimirov, Patrik K. E. Magnusson & Karolina A. Aberg. (2016) A Whole Methylome CpG-SNP Association Study of Psychosis in Blood and Brain Tissue. Schizophrenia Bulletin 42:4, pages 1018-1026.
Crossref
Christoph Bock, Florian Halbritter, Francisco J Carmona, Sascha Tierling, Paul Datlinger, Yassen Assenov, María Berdasco, Anke K Bergmann, Keith Booher, Florence Busato, Mihaela Campan, Christina Dahl, Christina M Dahmcke, Dinh Diep, Agustín F Fernández, Clarissa Gerhauser, Andrea Haake, Katharina Heilmann, Thomas Holcomb, Dianna Hussmann, Mitsuteru Ito, Ruth Kläver, Martin Kreutz, Marta Kulis, Virginia Lopez, Shalima S Nair, Dirk S Paul, Nongluk Plongthongkum, Wenjia Qu, Ana C Queirós, Frank Reinicke, Guido Sauter, Thorsten Schlomm, Aaron Statham, Clare Stirzaker, Ruslan Strogantsev, Rocío G Urdinguio, Kimberly Walter, Dieter Weichenhan, Daniel J Weisenberger, Stephan Beck, Susan J Clark, Manel Esteller, Anne C Ferguson-Smith, Mario F Fraga, Per Guldberg, Lise Lotte Hansen, Peter W Laird, José I Martín-Subero, Anders O H Nygren, Ralf Peist, Christoph Plass, David S Shames, Reiner Siebert, Xueguang Sun, Jörg Tost, Jörn Walter & Kun Zhang. (2016) Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. Nature Biotechnology 34:7, pages 726-737.
Crossref
Haijing Wu, Ming Zhao, Lina Tan & Qianjin Lu. (2016) The key culprit in the pathogenesis of systemic lupus erythematosus: Aberrant DNA methylation. Autoimmunity Reviews 15:7, pages 684-689.
Crossref
A. A. Ponomaryova, E. Y. Rykova, N. V. Cherdyntseva, A. A. Bondar, A. Y. Dobrodeev, A. A. Zavyalov, S. A. Tuzikov, L. O. Bryzgalov, T. I. Merkulova, V. V. Vlassov & P. P. Laktionov. (2016) Epigenetic probes for lung cancer monitoring: Line-1 methylation pattern in blood-circulating DNA. Russian Journal of Genetics: Applied Research 6:1, pages 99-104.
Crossref
Hui-Bo Chang, Ji-Zhen Zou, Cai He, Rui Zeng, Yuan-Yuan Li, Fei-Fei Ma, Zhuo Liu, Hui Ye & Jian-Xin Wu. (2015) Association between Long Interspersed Nuclear Element-1 Methylation and Relative Telomere Length in Wilms Tumor. Chinese Medical Journal 128:22, pages 3055-3061.
Crossref
Kurinji Pandiyan, Peter A. Jones & Stephen B. Baylin. 2015. Epigenetics for Drug Discovery. Epigenetics for Drug Discovery 249 266 .
Hyang-Min Byun & Timothy M. Barrow. 2015. Mitochondrial Medicine. Mitochondrial Medicine 271 283 .
Yoshifumi Baba, Asuka Murata, Masayuki Watanabe & Hideo Baba. (2013) Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer. Surgery Today 44:10, pages 1807-1816.
Crossref
M Grövdal, M Karimi, M Tobiasson, L Reinius, M Jansson, K Ekwall, J Ungerstedt, J Kere, D Greco & E Hellström-Lindberg. (2013) Azacitidine induces profound genome-wide hypomethylation in primary myelodysplastic bone marrow cultures but may also reduce histone acetylation. Leukemia 28:2, pages 411-413.
Crossref
Kunle Odunsi, Junko Matsuzaki, Smitha R. James, Paulette Mhawech-Fauceglia, Takemasa Tsuji, Austin Miller, Wa Zhang, Stacey N. Akers, Elizabeth A. Griffiths, Anthony Miliotto, Amy Beck, Carl A. Batt, Gerd Ritter, Shashikant Lele, Sacha Gnjatic & Adam R. Karpf. (2014) Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer. Cancer Immunology Research 2:1, pages 37-49.
Crossref
Antonella Poloni, Gaia Goteri, Antonio Zizzi, Federica Serrani, Silvia Trappolini, Benedetta Costantini, Marianna Mariani, Attilio Olivieri, Massimo Catarini, Riccardo Centurioni, Francesco Alesiani, Federica Giantomassi, Daniela Stramazzotti, Simona Biagetti, Simona Alfonsi, Eleonora Berardinelli & Pietro Leoni. (2013) Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. European Journal of Haematology 91:3, pages 219-227.
Crossref
Georg Johnen, Peter Rozynek, Yvonne von der Gathen, Oleksandr Bryk, Ricarda Zdrenka, Christian Johannes, Daniel G. Weber, O?Brien Igwilo-Okuefuna, Irina Raiko, J?rg Hippler, Thomas Br?ning & Elke Dopp. (2013) Cross-Contamination of a UROtsa Stock with T24 Cells ? Molecular Comparison of Different Cell Lines and Stocks. PLoS ONE 8:5, pages e64139.
Crossref
Dominique J.P.M. Stumpel, Pauline Schneider, Eddy H.J. van Roon, Rob Pieters & Ronald W. Stam. (2013) Absence of global hypomethylation in promoter hypermethylated Mixed Lineage Leukaemia-rearranged infant acute lymphoblastic leukaemia. European Journal of Cancer 49:1, pages 175-184.
Crossref
Aditi Hazra & Shuji Ogino. 2012. Epigenomics. Epigenomics 491 504 .
Shiro Iwagami, Yoshifumi Baba, Masayuki Watanabe, Hironobu Shigaki, Keisuke Miyake, Satoshi Ida, Yohei Nagai, Takatsugu Ishimoto, Masaaki Iwatsuki, Yasuo Sakamoto, Yuji Miyamoto & Hideo Baba. (2011) Pyrosequencing Assay to Measure LINE-1 Methylation Level in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology 19:8, pages 2726-2732.
Crossref
Si-Yuan PENG, Jie ZHANG, Mei-Ping TIAN, Zhan-Lin WANG & He-Qing SHEN. (2012) Determination of Global DNA Methylation in Biological Samples by Liquid Chromatography-Tandem Mass Spectrometry. Chinese Journal of Analytical Chemistry 40:8, pages 1201-1206.
Crossref
Andrea Baccarelli, Franca Rusconi, Valentina Bollati, Dolores Catelan, Gabriele Accetta, Lifang Hou, Fabio Barbone, Pier Alberto Bertazzi & Annibale Biggeri. (2012) Nasal cell DNA methylation, inflammation, lung function and wheezing in children with asthma. Epigenomics 4:1, pages 91-100.
Crossref
Mukesh Verma. 2012. Cancer Epigenetics. Cancer Epigenetics 467 480 .
Luca Sigalotti, Elisabetta Fratta, Ettore Bidoli, Alessia Covre, Giulia Parisi, Francesca Colizzi, Sandra Coral, Samuele Massarut, John M Kirkwood & Michele Maio. (2011) Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients. Journal of Translational Medicine 9:1.
Crossref
Guru Sonpavde, Ana M. Aparicio, Feng Zhan, Brittany North, Robert DeLaune, Lawrence E. Garbo, Steven R. Rousey, Ralph E. Weinstein, Lianchun Xiao, Kristi A. Boehm, Lina Asmar, Mark T. Fleming, Matthew D. Galsky, William R. Berry & Daniel D. Von Hoff. (2011) Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer. Urologic Oncology: Seminars and Original Investigations 29:6, pages 682-689.
Crossref
Nakarin Kitkumthorn & Apiwat Mutirangura. (2011) Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications. Clinical Epigenetics 2:2, pages 315-330.
Crossref
Chandrika J. Piyathilake, Maurizio Macaluso, Ronald D. Alvarez, Min Chen, Suguna Badiga, Nuzhat R. Siddiqui, Jeffrey C. Edberg, Edward E. Partridge & Gary L. Johanning. (2011) A higher degree of LINE-1 methylation in peripheral blood mononuclear cells, a one-carbon nutrient related epigenetic alteration, is associated with a lower risk of developing cervical intraepithelial neoplasia. Nutrition 27:5, pages 513-519.
Crossref
Ajjai S Alva, Noah M Hahn, Ana M Aparicio, Rakesh Singal, Sarvari Yellapragada & Guru Sonpavde. (2011) Hypomethylating agents for urologic cancers. Future Oncology 7:3, pages 447-463.
Crossref
Shimul Chowdhury, Mario A. Cleves, Stewart L. MacLeod, S. Jill James, Weizhi Zhao & Charlotte A. Hobbs. (2011) Maternal DNA hypomethylation and congenital heart defects. Birth Defects Research Part A: Clinical and Molecular Teratology 91:2, pages 69-76.
Crossref
Simon R. Corrie, Pavel Sova, Qinghua Feng, Tiffany Blair, Nancy B. Kiviat & Matt Trau. (2011) Bisulfite-free analysis of 5MeC-binding proteins and locus-specific methylation density using a microparticle-based flow cytometry assay. The Analyst 136:4, pages 688-691.
Crossref
Thomas Mikeska, Jörg Felsberg, Chelsee A. Hewitt & Alexander Dobrovic. 2011. Epigenetics Protocols. Epigenetics Protocols 33 53 .
Jiali Si, Yanis A. Boumber, Jingmin Shu, Taichun Qin, Saira Ahmed, Rong He, Jaroslav Jelinek & Jean-Pierre J. Issa. (2010) Chromatin Remodeling Is Required for Gene Reactivation after Decitabine-Mediated DNA Hypomethylation. Cancer Research 70:17, pages 6968-6977.
Crossref
Paul M. HowellJr.Jr., Zixing Liu & Hung T. Khong. (2010) Demethylating Agents in the Treatment of Cancer. Pharmaceuticals 3:7, pages 2022-2044.
Crossref
Natsumi Irahara, Katsuhiko Nosho, Yoshifumi Baba, Kaori Shima, Neal I. Lindeman, Aditi Hazra, Eva S. Schernhammer, David J. Hunter, Charles S. Fuchs & Shuji Ogino. (2010) Precision of Pyrosequencing Assay to Measure LINE-1 Methylation in Colon Cancer, Normal Colonic Mucosa, and Peripheral Blood Cells. The Journal of Molecular Diagnostics 12:2, pages 177-183.
Crossref
Thushangi N. Pathiraja, Vered Stearns & Steffi Oesterreich. (2010) Epigenetic Regulation in Estrogen Receptor Positive Breast Cancer—Role in Treatment Response. Journal of Mammary Gland Biology and Neoplasia 15:1, pages 35-47.
Crossref
Lisa A Cowan, Sundeep Talwar & Allen S Yang. (2010) Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors. Epigenomics 2:1, pages 71-86.
Crossref
Triantafillos Liloglou & John K. Field. 2010. Epigenetics and Cancer, Part B. Epigenetics and Cancer, Part B 177 207 .